We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

UHPLC- Robust Technology Built to Perform

Article   Aug 10, 2018 | By Martin Greiner, Marketing Manager, LC Core Systems.

 
UHPLC- Robust Technology Built to Perform

Credit: Agilent Technologies.

 
 
Advertisement
 

RELATED ARTICLES

Keep Up-to-Date With COVID-19 Vaccine Development

Article

Technology Networks is committed to keeping you updated with the latest research in this space. In this article, you'll find a curation of our latest COVID-19 vaccine-related content.

READ MORE

A New Way To Characterize Glycans From SARS-CoV-2's Spike Protein

Article

Dr Rod Chalk, head of mass spectrometry at The Centre for Medicines Discovery (previously the Structural Genomics Consortium) has developed a novel mass spectrometry-based method for characterizing glycans from the Spike protein. In this interview, Chalk discusses the method and how it can be adopted in SARS-CoV-2 research and beyond.

READ MORE

Stay Up-to-Date With COVID-19 Drug Development

Article

Whilst the world waits for an effective COVID-19 vaccine to be developed, researchers are working tirelessly to design new drugs and repurpose existing drugs against the novel coronavirus SARS-CoV-2.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Applied Sciences Diagnostics Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE